Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

v3.4.0.3
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2016
Notes Tables  
Schedule of Franchisor Disclosure [Table Text Block]
    Three Months Ended
March 31,
Franchised clinics:   2016   2015
Clinics open at beginning of period     265       242  
Opened during the period     14       13  
Acquired during the period     -       (10 )
Closed during the period     (2 )     (4 )
Clinics in operation at the end of the period     277       241  
    Three Months Ended
March 31,
Company-owned or managed clinics:   2016   2015
Clinics open at beginning of period     47       4  
Opened during the period     7       -  
Acquired during the period     -       10  
Closed during the period     -       (2 )
Clinics in operation at the end of the period     54       12  
                 
Total clinics in operation at the end of the period     331       253  
                 
Clinics licenses sold but not yet developed     146       254  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
    Three Months Ended
March 31,
    2016   2015
         
Net loss   $ (3,525,134 )   $ (1,903,723 )
                 
Weighted average common shares outstanding - basic     12,567,901       9,662,502  
Effect of dilutive securities:                
Stock options     -       -  
Weighted average common shares outstanding - diluted     12,567,901       9,662,502  
                 
Basic and diluted loss per share   $ (0.28 )   $ (0.20 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
    Three Months Ended
March 31,
    2016   2015
Unvested restricted stock     292,466       522,356  
Stock options     768,625       366,995  
Warrants     90,000       90,000